Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/46763
Title: The Longitudinal Evolution of Post-COVID-19 Outcomes Among Hemodialysis Patients in Turkey
Authors: Ozturk, Savas
Turgutalp, Kenan
Arici, Mustafa
Gorgulu, Numan
Tonbul, Halil Zeki
Eren, Necmi
Gencer, Vedat
Ayli, Mehmet Deniz
Pembegul, Irem
Dolarslan, Murside Esra
Ural, Zeynep
Colak, Hulya
Ozler, Tuba Elif
Can, Ozgur
Demir, Mehmet Emin
Altunoren, Orcun
Huddam, Bulent
Onec, Kursad
Demirelli, Bulent
Aydin, Zeki
Altun, Eda
Alagoz, Selma
Ayar, Yavuz
Eser, Zeynep Ebru
Berktas, Bayram
Yilmaz, Zulfukar
Ates, Eser Uslu
Yuksel, Enver
Sahin, Gizem Kumru
Aktar, Merve
Cebeci, Egemen
Dursun, Belda
Kocak, Sibel Yucel
Yildiz, Abdulmecit
Kazan, Sinan
Gok, Mahmut
Sengul, Erkan
Tugcu, Murat
Ozturk, Ramazan
Kahvecioglu, Serdar
Kara, Ekrem
Kaya, Bulent
Sahin, Garip
Sakaci, Tamer
Sipahi, Savas
Kurultak, Ilhan
Durak, Beyza Algul
Altiparmak, Mehmet Riza
Ecder, Sabahat Alisir
Karadag, Serhat
Dincer, Mevlut Tamer
Ozer, Hakan
Bek, Sibel Gokcay
Ulu, Memnune Sena
Gungor, Ozkan
Bakir, Elif Ari
Odabas, Ali Riza
Seyahi, Nurhan
Yildiz, Alaattin
Ates, Kenan
Keywords: COVID-19
hemodialysis
nationwide study
outcome
Mortality-Rates
Covid-19
Transplant
Publisher: Elsevier Science Inc
Abstract: Introduction: Hemodialysis (HD) patients have increased risk for short-term adverse outcomes of COVID-19. However, complications and survival at the post-COVID-19 period have not been published extensively.Methods: We conducted a national, multicenter observational study that included adult maintenance HD patients recovered from confirmed COVID-19. A control HD group without COVID-19 was selected from patients in the same center. We investigated the characteristics and outcomes in the follow-up of HD patients and compare them with the non-COVID-19 group.Results: A total of 1223 patients (635 patients in COVID-19 group, 588 patients in non-COVID-19 group) from 47 centers were included in the study. The patients' baseline and HD characteristics were almost similar. The 28th-day mortality and mortality between 28th day and 90th day were higher in the COVID-19 group than non-COVID-19 group (19 [3.0%] patients vs. none [0%]; 15 [2.4%] patients vs. 4 [0.7%] patients, respectively). The presence of respiratory symptoms, rehospitalization, need for home oxygen therapy, lower respiratory tract infection, and arteriovenous (AV) fistula thrombosis was significantly higher in the COVID-19 group in both the first 28 days and between 28 and 90 days. In the multivariable analysis, age (odds ratio [OR] [95% CI]: 1.029 [1.004-1.056]), group (COVID-19 group vs. non-COVID-19 group) (OR [95% CI]: 7.258 [2.538-20.751]), and vascular access type (tunneled catheter/AV fistula) (OR [95% CI]: 2.512 [1.249-5.051]) were found as independent parameters related to 90-day mortality.Conclusion: In the post-COVID-19 period, maintenance HD patients who have had COVID-19 have increased rehospitalization, respiratory problems, vascular access problems, and high mortality compared with the non-COVID-19 HD patients.
URI: https://doi.org/10.1016/j.ekir.2022.03.017
https://hdl.handle.net/11499/46763
ISSN: 2468-0249
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
1-s2.0-S2468024922012372-main.pdf763 kBAdobe PDFView/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

10
checked on Oct 13, 2024

WEB OF SCIENCETM
Citations

6
checked on Oct 22, 2024

Page view(s)

56
checked on Aug 24, 2024

Download(s)

20
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.